These data indicate that p42-mediated proteasomal degradation of p85 occurs not only in glioblastoma but also in other human cancer cells such as breast cancer cells, and might be a general tumor suppressing mechanism of p42 Ebp1. This evidence concerns the gene PA2G4 and neoplasm.